Health Care & Life Sciences » Biotechnology | BELLUS Health Inc.

BELLUS Health Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,967.00
12,307.00
9,702.00
6,834.00
23,888.00
48,906
Total Accounts Receivable
174.00
1,053.00
813.00
810.00
2,098.00
809
Other Current Assets
831.00
160.00
2,614.00
685.00
84.00
1,149
Total Current Assets
16,972.00
13,520.00
13,129.00
8,329.00
26,070.00
50,864
Total Investments and Advances
4,861.00
600.00
798.00
689.00
50.00
50
Long-Term Note Receivable
-
896.00
512.00
-
-
-
Intangible Assets
542.00
542.00
542.00
542.00
2,359.00
2,359
Other Assets
1,255.00
1,150.00
32.00
24.00
19.00
27
Total Assets
23,630.00
16,708.00
15,013.00
9,584.00
28,498.00
53,300
Accounts Payable
280.00
69.00
93.00
126.00
479.00
Other Current Liabilities
2,981.00
3,585.00
4,478.00
1,091.00
1,731.00
Total Current Liabilities
3,261.00
3,654.00
4,571.00
1,217.00
2,210.00
Long-Term Debt
5,188.00
-
-
-
-
Other Liabilities
4,363.00
3,546.00
70.00
104.00
-
Total Liabilities
12,812.00
7,200.00
4,641.00
1,321.00
2,210.00
Common Equity (Total)
9,695.00
8,398.00
9,041.00
8,263.00
26,288.00
Total Shareholders' Equity
9,695.00
8,398.00
9,041.00
8,263.00
26,288.00
Total Equity
10,818.00
9,508.00
10,372.00
8,263.00
26,288.00
Liabilities & Shareholders' Equity
23,630.00
16,708.00
15,013.00
9,584.00
28,498.00
Accumulated Minority Interest
1,123.00
1,110.00
1,331.00
-
-

About BELLUS Health

View Profile
Address
275 Armand-Frappier boulevard
Laval Québec H7V 4A7
Canada
Employees -
Website http://www.bellushealth.com
Updated 07/08/2019
BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on April 12, 2012 and is headquartered in Laval, Canada.